One landmark clinical paper, dissected every week.

pulsosaudepodcast@gmail.com

ARTICLE REFERENCE:

• Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
• Authors: Teachey DT, Devidas M, Wood BL et al.
• Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• https://doi.org/10.1200/JCO.21.02678

One landmark clinical paper, dissected every week.

pulsosaudepodcast@gmail.com

ARTICLE REFERENCE:

• A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
• Authors: Garcia-Manero G, Podoltsev NA, Othus M et al.
• Journal: Leukemia
• https://doi.org/10.1038/s41375-023-02073-x

One landmark clinical paper, dissected every week.

pulsosaudepodcast@gmail.com

ARTICLE REFERENCE:

• Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study
• Authors: Popat R, Beksac M, Dimopoulos MA et al.
• Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• https://doi.org/10.1200/JCO-25-00924

Weekly discussions on the latest evidence in hematologic oncology - from landmark trials to practice-changing papers.

pulsosaudepodcast@gmail.com

PAPER:

• Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
• Authors: Leleu X, Hulin C, Lambert J et al.
• Journal: Nature medicine
• https://doi.org/10.1038/s41591-024-03050-2

Weekly discussions on the latest evidence in hematologic oncology - from landmark trials to practice-changing papers.

pulsosaudepodcast@gmail.com

PAPER:

• Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
• Authors: Wang M, Jurczak W, Trneny M et al.
• Journal: The Lancet. Oncology
• https://doi.org/10.1016/S1470-2045(24)00682-X

Weekly discussions on the latest evidence in hematologic oncology - from landmark trials to practice-changing papers.

pulsosaudepodcast@gmail.com

PAPER:

• Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
• Authors: Peters C, Dalle JH, Locatelli F et al.
• Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• https://doi.org/10.1200/JCO.20.02529

Weekly discussions on the latest evidence in hematologic oncology - from landmark trials to practice-changing papers.

pulsosaudepodcast@gmail.com

PAPER:

• Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
• Authors: Byrd JC, Hillmen P, Ghia P et al.
• Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• https://doi.org/10.1200/JCO.21.01210

Weekly discussions on the latest evidence in hematologic oncology - from landmark trials to practice-changing papers.

pulsosaudepodcast@gmail.com

PAPER:

• A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

• Authors: Mascarenhas J, Kosiorek HE, Prchal JT et al.

• Journal: Blood
• https://doi.org/10.1182/blood.2021012743